AORT - Latest News

Artivion, Inc. (AORT), operates in Healthcare / Medical - Devices, trades on NYSE.

Market capitalization stands near $1.15B. Trailing twelve-month P/E ratio is 97.09. Beta to the broader market is 1.26.

The article list below shows the most recent AORT headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.

Recent AORT Headlines

Artivion: PMA Approval Supports Accelerating Growth And Margin Expansion

seekingalpha.com - Jun 30, 2026

Artivion benefits from FDA premarket approval of AMDS, removing adoption barriers and unlocking a $150M U. S.

Artivion Announces U.S. FDA Approval of the AMDS Hybrid Prosthesis

prnewswire.com - Jun 29, 2026

ATLANTA, June 29, 2026 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today a

Artivion to Participate in the 2026 Truist Securities MedTech Conference

prnewswire.com - Jun 10, 2026

ATLANTA, June 10, 2026 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, announc

Endospan Announces Closing of Acquisition by Artivion, Inc., Following FDA PMA Approval of the NEXUS® Aortic Arch System

gurufocus.com - May 18, 2026

Endospan, a pioneer in endovascular solutions for complex aortic pathologies, today announced that Artivion, Inc.

Endospan Announces Closing of Acquisition by Artivion, Inc., Following FDA PMA Approval of the NEXUS® Aortic Arch System

businesswire.com - May 18, 2026

HERZLIYA, Israel--(BUSINESS WIRE)-- #aortaEd--Endospan, a pioneer in endovascular solutions for complex aortic pathologies, today announced that Artiv

How News Affects AORT Options Pricing

Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track AORT's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.

Frequently asked AORT news questions

What is the latest AORT news headline?

The most recent AORT headline (Jun 30, 2026) is "Artivion: PMA Approval Supports Accelerating Growth And Margin Expansion". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.

How fresh is the AORT news on this page?

News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.

What AORT news moves options pricing?

Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.

How can I track unusual AORT options activity related to news?

Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.